Clinical trial
Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers
NCT00483353 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00483353 |
|---|---|
| Title | Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers |
| Official title | A Pilot Study to Explore the Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers in Subjects With Seasonal Allergic Rhinitis |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Seasonal Allergic Rhinitis |
| Intervention type | Procedure |
| Interventions | Intra-nasal allergen challenge with Phleum pratense., Collection of nasal effluent using filter paper., Measurement of nasal congestion using acoustic rhinometry. |
| Enrollment | 6 |
| Start date | Jul 1, 2007 |
| First posted | Jun 7, 2007 |
| Last update posted | Jun 17, 2008 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: